Riken Vitamin Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
10,244.00
12,706.00
11,909.00
7,857.00
20,313.00
-7.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3,500.00
-1,863.00
-1,453.00
-3,240.00
-1,155.00
3,927.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
5,963.00
7,892.00
10,451.00
7,835.00
6,823.00
7,625.00
Cash Flow from Investing Activities
1,747.00
353.00
-554.00
-2,034.00
-3,661.00
-2,288.00
Cash Flow from Financing Activities
-8,040.00
-9,965.00
-7,084.00
-4,578.00
-7,565.00
-180.00
Net Cash Inflow / Outflow
219.00
-1,307.00
3,485.00
1,592.00
-3,592.00
5,052.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
549.00
413.00
672.00
369.00
811.00
-105.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Riken Vitamin Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
10244
17641
-7,397.00
-41.93%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3500
-959
-2,541.00
-264.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
5963
13204
-7,241.00
-54.84%
Cash Flow from Investing Activities
1747
-3438
5,185.00
150.81%
Cash Flow from Financing Activities
-8040
-7372
-668.00
-9.06%
Net Cash Inflow / Outflow
219
2389
-2,170.00
-90.83%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
549
-5
554.00
11080.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -24.44% vs -24.49% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
5,963.00
7,892.00
-24.44%






